This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Feb 15;58(1488):21-3.

Selexipag (Uptravi) for pulmonary arterial hypertension

No authors listed

PMID: 26859660

Selexipag (Uptravi) for pulmonary arterial hypertension

No authors listed. Med Lett Drugs Ther. 2016.

. 2016 Feb 15;58(1488):21-3.

PMID: 26859660

No abstract available

PubMed Disclaimer

Similar articles

Selexipag: First Global Approval.
Scott LJ. Scott LJ. Drugs. 2016 Mar;76(3):413-8. doi: 10.1007/s40265-016-0549-4. Drugs. 2016. PMID: 26846322 Review.
Selexipag: A Review in Pulmonary Arterial Hypertension.
Duggan ST, Keam SJ, Burness CB. Duggan ST, et al. Am J Cardiovasc Drugs. 2017 Feb;17(1):73-80. doi: 10.1007/s40256-016-0209-9. Am J Cardiovasc Drugs. 2017. PMID: 27988834 Review.
Selexipag for the treatment of pulmonary arterial hypertension.
Noel ZR, Kido K, Macaulay TE. Noel ZR, et al. Am J Health Syst Pharm. 2017 Aug 1;74(15):1135-1141. doi: 10.2146/ajhp160798. Epub 2017 May 22. Am J Health Syst Pharm. 2017. PMID: 28533253 Review.
Population Modeling of Selexipag Pharmacokinetics and Clinical Response Parameters in Patients With Pulmonary Arterial Hypertension.
Krause A, Machacek M, Lott D, Hurst N, Bruderer S, Dingemanse J. Krause A, et al. CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):477-485. doi: 10.1002/psp4.12202. Epub 2017 May 27. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28556581 Free PMC article. Clinical Trial.
Safety concerns regarding selexipag in pulmonary arterial hypertension.
Noel ZR. Noel ZR. Am J Health Syst Pharm. 2018 Apr 1;75(7):420. doi: 10.2146/ajhp170884. Am J Health Syst Pharm. 2018. PMID: 29572307 No abstract available.

See all similar articles

Cited by

Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
Burger CD, Ozbay AB, Lazarus HM, Riehle E, Montejano LB, Lenhart G, White RJ. Burger CD, et al. J Manag Care Spec Pharm. 2018 Aug;24(8):834-842. doi: 10.18553/jmcp.2018.17391. Epub 2018 Feb 13. J Manag Care Spec Pharm. 2018. PMID: 29436260 Free PMC article.
Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes.
Burger CD, Ghandour M, Padmanabhan Menon D, Helmi H, Benza RL. Burger CD, et al. Clinicoecon Outcomes Res. 2017 Nov 24;9:731-739. doi: 10.2147/CEOR.S119117. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 29200882 Free PMC article. Review.
Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies.
Tsai J, Malik S, Tjen-A-Looi SC. Tsai J, et al. Life (Basel). 2024 Oct 4;14(10):1265. doi: 10.3390/life14101265. Life (Basel). 2024. PMID: 39459565 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Medical Letter on Drugs and Therapeutics
Medical
- MedlinePlus Health Information